MetaCap

Lexeo Therapeutics (LXEO) Stock Chart

NASDAQ: LXEOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

2.96+0.01 (+0.34%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

LXEO technical summary

LXEO is trading 8.2% below its 50-day simple moving average of $3.22 and 39.3% below its 200-day average of $4.88. The 50-day average is below the 200-day average, a configuration technical analysts associate with a longer-term downtrend. The 14-day Relative Strength Index (RSI) is 46.9, within the neutral 30 to 70 band.

Over the past year, the stock ranged from $2.55 (Oct 19, 2026) to $10.99 (Dec 23, 2025); the current price sits 5% of the way from the low to the high. Annualized 30-day volatility is 93.7%. Based on the last session's high, low and close, the classic pivot point is $3.03, with first resistance at $3.17 and first support at $2.82.

These indicators describe past price behavior for Lexeo Therapeutics; they are not predictions.

Summary generated from market data by MetaCap's automated system. Methodology

Technical indicators

Beta
—
1Y high
10.99 (Dec 23)
1Y low
2.55 (Oct 19)
Last close
2.96

LXEO price performance

1 week

+3.14%

1 month

-1.33%

3 months

-39.34%

6 months

-42.07%

Year to date

-70.19%

1 year

-67.33%

3 years

-73.81%

LXEO price return, excluding dividends.

Moving averages

Simple and exponential moving averages
PeriodSimple (SMA)Exponential (EMA)
5-day2.99Price below2.96Price below
10-day3.00Price below2.98Price below
20-day3.00Price below3.01Price below
50-day3.22Price below3.31Price below
100-day3.97Price below3.90Price below
200-day4.88Price below5.08Price below

Moving averages are computed from daily closing prices over the past year. What is a moving average?

Pivot points

Classic pivot points
LevelPrice
Resistance 3 (R3)3.53
Resistance 2 (R2)3.39
Resistance 1 (R1)3.17
Pivot point3.03
Support 1 (S1)2.82
Support 2 (S2)2.68
Support 3 (S3)2.46

Classic floor-trader pivots from the last session's high, low and close. How pivot points work

Learn technical analysis